Chief Scientific Officer Dr. Scott Jones was selected as a moderator at the BioMedSA BioFest Invest event.
On April 23, BioFest Invest 2025 took place at the University of the Incarnate Word in San Antonio. The event connected Texas bioscience companies with national investors, focusing on healthcare innovation and veteran healthcare.
Innovative Strategies for Accessing the VA Healthcare System
A key panel, “Innovative Strategies for Accessing the VA’s Market”, discussed how bioscience startups can navigate the complex U.S. Department of Veterans Affairs (VA) system. The panel featured experts like:
- Dr. Scott Jones, Senior VP and Chief Scientific Officer, BioBridge Global
- Michelle Trimble, CEO, Foundation for Advancing Veterans Health Research
- Divya Singhal, U.S. Department of Veterans Affairs
- Scott Robery, Advisor, Vortac Medical
Dr. Scott Jones shared insights from his expertise in regenerative medicine and clinical research. As BioBridge Global’s Chief Scientific Officer, he leads efforts to improve patient outcomes for veterans through innovative therapies.
Collaboration and Funding Opportunities for Healthcare Innovators
The event also featured a startup pitch competition, where companies pitched their ideas to investors. Winners received $10,000 in funding and resources to advance their projects.
This event offered key takeaways for hospital staff, researchers, and clinicians in veteran-centered healthcare. It provided strategies for navigating the VA system and advancing research for veterans.
Stay Engaged with Bioscience Innovation
Hospital teams and innovators interested in veteran healthcare should stay updated on future opportunities. BioFest Invest 2025 connected healthcare leaders and offered valuable resources for advancing healthcare innovation.tunities and review takeaways from the event to stay engaged in this rapidly evolving space.
